Editorial
doi: 10.3324/haematol.2009.019141.
Pathophysiology and treatment of the myelodysplastic syndrome with isolated 5q deletion
- PMID: 20207839
- PMCID: PMC2833060
- DOI: 10.3324/haematol.2009.019141
Item in Clipboard
Editorial
Pathophysiology and treatment of the myelodysplastic syndrome with isolated 5q deletion
Haematologica.
2010 Mar.
No abstract available
Figures
Overview of the pathophysiology of the 5q- syndrome.
Similar articles
-
[The 5q- syndrome].Rev Prat. 2010 Dec 20;60(10):1420-2. Rev Prat. 2010. PMID: 21425544 French. No abstract available.
-
Very short-term lenalidomide treatment associated with durable resolution of anemia in a patient with myelodysplastic syndrome with chromosome 5q deletion.Ann Hematol. 2012 Feb;91(2):309-10. doi: 10.1007/s00277-011-1263-7. Epub 2011 May 28. Ann Hematol. 2012. PMID: 21625998 No abstract available.
-
Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion.Leuk Res. 2011 Sep;35(9):e175-6. doi: 10.1016/j.leukres.2011.05.020. Epub 2011 Jun 11. Leuk Res. 2011. PMID: 21658768 No abstract available.
-
Pleiotropic mechanisms of action of lenalidomide efficacy in del(5q) myelodysplastic syndromes.Expert Rev Anticancer Ther. 2010 Oct;10(10):1663-72. doi: 10.1586/era.10.135. Expert Rev Anticancer Ther. 2010. PMID: 20942636 Review.
-
The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes.Curr Opin Hematol. 2007 Mar;14(2):123-9. doi: 10.1097/MOH.0b013e328016847a. Curr Opin Hematol. 2007. PMID: 17255789 Review.
Cited by
-
Important genes in the pathogenesis of 5q- syndrome and their connection with ribosomal stress and the innate immune system pathway.Leuk Res Treatment. 2012;2012:179402. doi: 10.1155/2012/179402. Epub 2012 Feb 13. Leuk Res Treatment. 2012. PMID: 23213547 Free PMC article.
-
A primary care approach to myelodysplastic syndromes.Korean J Fam Med. 2014 May;35(3):111-8. doi: 10.4082/kjfm.2014.35.3.111. Epub 2014 May 22. Korean J Fam Med. 2014. PMID: 24921029 Free PMC article. Review.
-
L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway.Blood. 2012 Sep 13;120(11):2214-24. doi: 10.1182/blood-2011-10-382986. Epub 2012 Jun 25. Blood. 2012. PMID: 22734070 Free PMC article.
-
Current Management and New Developments in the Treatment of Myelodysplastic Syndrome.Cancer Treat Res. 2021;181:115-132. doi: 10.1007/978-3-030-78311-2_7. Cancer Treat Res. 2021. PMID: 34626358 Review.
-
NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes.Leukemia. 2013 Oct;27(10):2077-81. doi: 10.1038/leu.2013.160. Epub 2013 May 27. Leukemia. 2013. PMID: 23708912 Free PMC article. No abstract available.
References
-
- Giagounidis AA, Germing U, Haase S, Hildebrandt B, Schlegelberger B, Schoch C, et al. Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31. Leukemia. 2004;18(1):113–9. - PubMed
-
- Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008.
-
- Nilsson L, Astrand-Grundstrom I, Arvidsson I, Jacobsson B, Hellstrom-Lindberg E, Hast R, et al. Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood. 2000;96(6):2012–21. - PubMed
-
- Jaju RJ, Jones M, Boultwood J, Kelly S, Mason DY, Wainscoat JS, et al. Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome. Genes Chromosomes Cancer. 2000;29(3):276–80. - PubMed
-
- Kiladjian JJ, Bourgeois E, Lobe I, Braun T, Visentin G, Bourhis JH, et al. Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes. Leukemia. 2006;20(3):463–70. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
